Showing results (2421-2430 of 2,573) with videos related to

Sort By:
Pageof 258
Nature Communications|May 12, 2021
Peripheral-specific Y1 receptor antagonism increases thermogenesis and protects against diet-induced obesityChenxu Yan, Tianshu Zeng, Kailun Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab GovitecanRebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2017
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteriaLeena Gandhi, Sai-Hong Ignatius Ou, Alice T Shaw, et al.
Sports Health|August 3, 2026
Association Between Sleep Duration and Recovery Trajectories After a Concussion in United States Service Academy Cadets and MidshipmenMichael J Aderman, Ruxandra Andriescu, Steven R Malvasi, et al.
Human Mutation|December 24, 2015
Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In VitroAna S A Cohen, Damian B Yap, M E Suzanne Lewis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.
The Oncologist|April 17, 2026
Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 AnalysisAlexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
The Oncologist|May 8, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysisAlexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
Ophthalmology Science|December 30, 2022
Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III StudyShwetha Mudalegundi, Robin D Ross, Jemma Larbelee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 1998
Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient studyM Jones, T Hagen, C A Boyle, et al.
Pageof 258